ATE382055T1 - Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren - Google Patents

Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren

Info

Publication number
ATE382055T1
ATE382055T1 AT01920759T AT01920759T ATE382055T1 AT E382055 T1 ATE382055 T1 AT E382055T1 AT 01920759 T AT01920759 T AT 01920759T AT 01920759 T AT01920759 T AT 01920759T AT E382055 T1 ATE382055 T1 AT E382055T1
Authority
AT
Austria
Prior art keywords
wnt
nucleic acids
acids encoding
related polypeptides
polypeptides
Prior art date
Application number
AT01920759T
Other languages
English (en)
Inventor
Luca Rastelli
Diane Pennica
Original Assignee
Curagen Corp
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Genentech Inc filed Critical Curagen Corp
Application granted granted Critical
Publication of ATE382055T1 publication Critical patent/ATE382055T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01920759T 2000-03-22 2001-03-22 Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren ATE382055T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19125800P 2000-03-22 2000-03-22

Publications (1)

Publication Number Publication Date
ATE382055T1 true ATE382055T1 (de) 2008-01-15

Family

ID=38885296

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01920759T ATE382055T1 (de) 2000-03-22 2001-03-22 Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren

Country Status (11)

Country Link
US (3) US20020098540A1 (de)
EP (1) EP1265914B1 (de)
JP (1) JP2003527849A (de)
AT (1) ATE382055T1 (de)
AU (2) AU2001247781C1 (de)
CA (1) CA2404216A1 (de)
DE (1) DE60132075T2 (de)
DK (1) DK1265914T3 (de)
ES (1) ES2298226T3 (de)
PT (1) PT1265914E (de)
WO (1) WO2001070775A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114644D0 (en) * 2001-06-15 2001-08-08 Oxford Glycosciences Uk Ltd Protein
EP1500665B1 (de) 2002-04-15 2011-06-15 Chugai Seiyaku Kabushiki Kaisha VERFAHREN ZUR HERSTELLUNG VON scDb-BIBLIOTHEKEN
DE602004021095D1 (de) 2003-01-21 2009-06-25 Chugai Pharmaceutical Co Ltd Verfahren zum screening der leichten kette eines antikörpers
WO2005042582A1 (ja) * 2003-11-04 2005-05-12 Chugai Seiyaku Kabushiki Kaisha 抗体の製造方法
WO2004111233A1 (ja) 2003-06-11 2004-12-23 Chugai Seiyaku Kabushiki Kaisha 抗体の製造方法
US20050251054A1 (en) * 2004-05-10 2005-11-10 Medpond, Llc Method and apparatus for measurement of autonomic nervous system function
EP1870458B1 (de) 2005-03-31 2018-05-09 Chugai Seiyaku Kabushiki Kaisha sc(Fv)2-STRUKTURISOMERE
CN101198698B (zh) 2005-03-31 2014-03-19 中外制药株式会社 通过调节多肽缔合制备多肽的方法
CN101237890A (zh) 2005-06-10 2008-08-06 中外制药株式会社 含有葡甲胺的蛋白质制剂的稳定剂及其利用
AU2006256030B2 (en) 2005-06-10 2012-06-21 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical compositions containing sc(Fv)2
EP2009101B1 (de) 2006-03-31 2017-10-25 Chugai Seiyaku Kabushiki Kaisha Antikörpermodifikationsverfahren für die aufreinigung eines bispezifischen antikörpers
WO2010004273A1 (en) 2008-07-07 2010-01-14 Oxford Nanopore Technologies Limited Base-detecting pore
EP2307540B1 (de) 2008-07-07 2017-04-19 Oxford Nanopore Technologies Limited Enzymporenstrukturen
GB0820927D0 (en) 2008-11-14 2008-12-24 Isis Innovation Method
WO2010086622A1 (en) 2009-01-30 2010-08-05 Oxford Nanopore Technologies Limited Adaptors for nucleic acid constructs in transmembrane sequencing
US20120100530A1 (en) * 2009-01-30 2012-04-26 Oxford Nanopore Technologies Limited Enzyme mutant
GB0905140D0 (en) 2009-03-25 2009-05-06 Isis Innovation Method
EP2673638B1 (de) 2011-02-11 2019-10-30 Oxford Nanopore Technologies Limited Mutante poren
IN2014DN00221A (de) 2011-07-25 2015-06-05 Oxford Nanopore Tech Ltd
JP6271505B2 (ja) 2012-04-10 2018-01-31 オックスフォード ナノポール テクノロジーズ リミテッド 変異体ライセニンポア
WO2014013259A1 (en) 2012-07-19 2014-01-23 Oxford Nanopore Technologies Limited Ssb method
GB201314695D0 (en) 2013-08-16 2013-10-02 Oxford Nanopore Tech Ltd Method
BR112015021788B1 (pt) 2013-03-08 2023-02-28 Oxford Nanopore Technologies Plc Métodos para mover uma ou mais helicases imobilizadas, para controlar o movimento de um polinucleotídeo alvo, para caracterizar um polinucleotídeo alvo e para controlar o carregamento de uma ou mais helicases em um polinucleotídeo alvo, uso de um poro de transmembrana e de um potencial aplicado e de um ou mais espaçadores, complexo, e, kit
GB201313477D0 (en) 2013-07-29 2013-09-11 Univ Leuven Kath Nanopore biosensors for detection of proteins and nucleic acids
CN105764922B (zh) 2013-09-27 2020-07-17 中外制药株式会社 多肽异源多聚体的制备方法
GB201403096D0 (en) 2014-02-21 2014-04-09 Oxford Nanopore Tech Ltd Sample preparation method
EP3137627B1 (de) 2014-05-02 2025-07-30 Oxford Nanopore Technologies plc Verfahren zur verbesserung der bewegung eines zielpolynukleotids bezüglich einer transmembranpore
KR20170042794A (ko) 2014-09-01 2017-04-19 브이아이비 브이지더블유 돌연변이체 csgg 포어
WO2016055778A1 (en) 2014-10-07 2016-04-14 Oxford Nanopore Technologies Limited Mutant pores
GB201418159D0 (en) 2014-10-14 2014-11-26 Oxford Nanopore Tech Ltd Method
SG11201803989WA (en) 2015-12-28 2018-06-28 Chugai Pharmaceutical Co Ltd Method for promoting efficiency of purification of fc region-containing polypeptide
GB201609220D0 (en) 2016-05-25 2016-07-06 Oxford Nanopore Tech Ltd Method
GB201807793D0 (en) 2018-05-14 2018-06-27 Oxford Nanopore Tech Ltd Method
CN114457052B (zh) * 2021-09-17 2024-02-27 厦门大学 一种抗肿瘤的多肽组合物及其应用

Also Published As

Publication number Publication date
ES2298226T3 (es) 2008-05-16
PT1265914E (pt) 2008-04-08
AU2001247781B2 (en) 2006-02-02
US20020098540A1 (en) 2002-07-25
JP2003527849A (ja) 2003-09-24
DE60132075T2 (de) 2009-03-12
DK1265914T3 (da) 2008-03-10
DE60132075D1 (de) 2008-02-07
AU2001247781C1 (en) 2006-08-17
EP1265914B1 (de) 2007-12-26
US20080206252A1 (en) 2008-08-28
AU4778101A (en) 2001-10-03
CA2404216A1 (en) 2001-09-27
US20050159373A1 (en) 2005-07-21
WO2001070775A2 (en) 2001-09-27
EP1265914A2 (de) 2002-12-18
WO2001070775A3 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
DE60132075D1 (de) Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
DE69131580D1 (de) GDF-1 und UOG1 Proteine
ATE368053T1 (de) Antimikrobielle peptide
GB9823897D0 (en) Immunotherapeutic methods and molecules
ATE229977T1 (de) Peptide mit antiproliferativen eigenschaften
ATE357526T1 (de) Modifizierte hcv peptid-impfstoffe
EP1117682A4 (de) Peptide
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
AU4945001A (en) Angiogenesis associated proteins, and nucleic acids encoding the same
WO2001098355A3 (en) Cgi-69 compositions and methods of use
ATE315646T1 (de) Leukocyten-aktivierender faktor
DE69936513D1 (de) Menschliche p51-gene und deren genprodukte
DE69831584T2 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
DE60037413D1 (de) Rekombinante adhesin-proteine aus haemophilus influenzae
ATE332373T1 (de) Menschlisches il-1 epsilon dna und polypeptide
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
WO2002072765A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2002097036A3 (en) Compositions and methods for adipose abundant protein
WO2002096355A3 (en) Compositions and methods for adipose abundant protein
HUP0001462A2 (en) Human toll-like receptor proteins, related reagents and methods
CO5400145A1 (es) Proteina asociada con enfermedad
WO2002068648A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these humans ras-like proteins, and uses thereof
WO2002061088A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
SE0002738D0 (sv) Electric actuator

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1265914

Country of ref document: EP